SpectraScience Adds Industry Veteran to Executive Team
...e appointment of its new Vice President of Sales, Christopher
Jackson, who has held senior sales positions at Adeza Biomedical Specialty
and most recently at Neomatrix, Inc.
"Chris brings to SpectraScience more than 24 years of sales and
marketing experience in the medical device and ...
Eligard(R) six-month formulation successfully completes European approval procedure
...me of the appeal in
German patent litigation commenced by Takeda Chemical Industries Ltd. and
Wako Pure Chemical Industries, Ltd. against Astellas and medigene
Germany with respect to Eligard may be unfavorable and could result in QLT
USA, Inc. being required to pay financial damages which could be
MediGene in Medical Technology
MediGene in Biological Technology
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... AbbeyMoor Collaborate to Develop Products to
Treat Prostate Diseases II-84
Dendreon Constructs Manufacturing Facility in New Jersey II-84
Introduces Prostate Cancer Drug in Italian Market II-85
Gen-Probe Introduces Innovative Test for Prostate Cancer in
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... (NASDAQ: BTRX ) INNOGENETICS NV (Euronext, Brussels: INNX) INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ: IART ) KV PHARMACEUTICAL CO (NYSE: KV/A) medigene
AG (Frankfurt, Germany: MDG) MENTOR CORP (NYSE: MNT ) MYLAN INC. (NYSE: MYL ) NUSKIN ENTERPRISES INC. (NYSE: NUS ) OMEGA PHARMA SA (Euronext, B...
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
...nts 18 years and older. Veregen(TM) is the first new
prescription treatment for external genital warts in ten years. Bradley
licensed the product from medigene
AG (Frankfurt: MDG) and has exclusive
marketing rights in the United States.
Veregen(TM) is the first botanical drug approved for prescription use